Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs UBS Group AG Registered Ordinary Shares — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while UBS Group AG Registered Ordinary Shares trades at $48.17 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 5.6× Royalty Pharma plc Class A Ordinary Shares's market cap, and UBS Group AG Registered Ordinary Shares pays the higher dividend (2.34%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and UBS Group AG Registered Ordinary Shares for 1 Days on average.
| RPRX | UBS | |
|---|---|---|
Market Cap | $25.27B | $142.70B |
Volume | 3,671,183 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $63.96 | $55.72 |
52-Week Low | $35.44 | $36.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $32.50B | $314.41B |
Dividend Yield | 1.66% | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
